What is the recommended intravenous furosemide (Lasix) dosing for an adult with acute hypertension and volume overload, without severe renal impairment or sulfonamide allergy?

Intravenous Furosemide Dosing for Acute Hypertension with Volume Overload

For adults with acute hypertension and volume overload, initiate IV furosemide at 20-40 mg as a slow IV push (over 1-2 minutes), with repeat dosing or dose escalation by 20 mg increments every 2 hours until adequate diuresis is achieved, up to a maximum single dose of 160 mg. 1

Initial Dosing Strategy

• Start with 20-40 mg IV furosemide given slowly over 1-2 minutes as the standard initial dose for volume overload 1
• If inadequate response occurs within 2 hours, administer another dose or increase by 20 mg increments 1
• Continue dose escalation every 2 hours until desired diuretic effect is obtained, with maximum single bolus dose of 160 mg 1

Context-Specific Considerations

Acute Pulmonary Edema (Hypertensive Emergency)

• Initial dose: 40 mg IV push over 1-2 minutes 1
• If inadequate response within 1 hour, increase to 80 mg IV push over 1-2 minutes 1
• Preferred agents for acute pulmonary edema include clevidipine, nitroglycerin, or nitroprusside alongside furosemide; beta blockers are contraindicated 2

Conservative Fluid Management Protocol (ARDS/Volume Overload)

When managing volume overload in the absence of shock, follow this structured approach 2:

Furosemide dosing algorithm:

• Begin with 20 mg bolus or 3 mg/h continuous infusion (or last known effective dose) 2
• Double each subsequent dose until oliguria reversal or intravascular pressure target achieved 2
• Maximum infusion rate: 24 mg/h or 160 mg bolus 2
• Do not exceed 620 mg/day total 2

Continuous Infusion for Refractory Cases

For patients requiring high-dose diuresis or with diuretic resistance:

• Add furosemide to normal saline, lactated Ringer's, or D5W after adjusting pH above 5.5 1
• Administer as controlled IV infusion at rate not exceeding 4 mg/min 1
• Continuous infusion produces significantly greater diuresis (12-26% increase in urine output) and natriuresis (11-33% increase in sodium excretion) compared to intermittent bolus dosing 3
• For severe heart failure with diuretic resistance, infusion rates of 20-160 mg/h have been used safely under careful monitoring 4

Critical Safety Parameters

Administration Precautions

• Never administer faster than recommended (1-2 minutes for bolus, ≤4 mg/min for infusion) to prevent ototoxicity 1
• Ensure pH of prepared infusion solution is weakly alkaline to neutral (pH >5.5) to prevent precipitation 1
• Do not mix with acidic solutions (labetalol, ciprofloxacin, amrinone, milrinone) as this causes precipitation 1

Monitoring Requirements

• Assess volume status before each dose; avoid in volume-depleted patients 2
• Monitor serum electrolytes, particularly potassium, closely during therapy 1
• Track urine output, weight changes, and renal function (creatinine) 1
• Withhold diuretics in dialysis-dependent patients or those with serum creatinine >3 mg/dL with oliguria 2

When Furosemide is NOT First-Line

In hypertensive emergencies WITHOUT volume overload, furosemide is not indicated 2. Preferred agents include:

• Acute aortic dissection: Esmolol or labetalol (target SBP ≤120 mmHg within 20 minutes) 2
• Acute coronary syndrome: Nitroglycerin, esmolol, labetalol, or nicardipine 2
• Malignant hypertension: Labetalol, nicardipine, or nitroprusside (reduce MAP by 20-25% over several hours) 2

Geriatric Considerations

• Start at the low end of the dosing range (20 mg) in elderly patients 1
• Titrate cautiously with careful monitoring of renal function and electrolytes 1

Common Pitfalls to Avoid

• Do not use furosemide as monotherapy for acute hypertension—it should be combined with appropriate antihypertensive agents based on the clinical scenario 2
• Avoid excessive diuresis leading to volume depletion, which can worsen renal function and cause hypotension 2
• Do not administer in volume-depleted states or with nitroglycerin in such patients 2
• Recognize contraindication in patients with sulfonamide allergy 2